Suicide Risk in Placebo-Controlled Studies of Major Depression - Concepedia

Concepedia

Publication | Closed Access

Suicide Risk in Placebo-Controlled Studies of Major Depression

113

Citations

23

References

2001

Year

Jitschak G. Storosum, Barbara J. van Zwieten, Wim van den Brink, Berthold P. R. Gersons, André W. Broekmans

American Journal of Psychiatry

Abstract

Fear of increased risk of attempted suicide in the placebo groups should not be an argument against performing short-term and long-term, placebo-controlled trials in major depression.

References

	Year	Citations
Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder Ellen Frank Archives of General Psychiatry	1991	1.9K
Suicide and Primary Affective Disorders Samuel B. Guzé, Eli Robins The British Journal of Psychiatry Primary Affective DisordersMental HealthBipolar DisorderPsychologySocial Sciences	1970	723
The Continuing Unethical Use of Placebo Controls Kenneth J. Rothman, Karin B. Michels New England Journal of Medicine	1994	666
Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical Trials Arif Khan, Heather Warner, Walter A. Brown Archives of General Psychiatry New AntidepressantsPsychotropic MedicationDrug Administration DatabasePsychopharmacologyPharmacotherapy	2000	479
Sertraline in the Prevention of Depression D.P. Doogan, Vincent Caillard The British Journal of Psychiatry	1992	246
Optimal Length of Continuation Therapy in Depression: A Prospective Assessment During Long-Term Fluoxetine Treatment Frederick W. Reimherr, Jay D. Amsterdam, Frederic M. Quitkin, American Journal of Psychiatry	1998	203
Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression S.A. Montgomery, G. Dunbar International Clinical Psychopharmacology PsychiatryMedicinePsychotropic MedicationMajor DepressionDepression	1993	190
A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression Stuart Montgomery, J Rasmussen, P. Tanghøj International Clinical Psychopharmacology PsychopharmacologyPharmacotherapyMental HealthRelapse PreventionSocial Sciences	1993	166
Epidemiological data suggest antidepressants reduce suicide risk among depressives Göran Isacsson, Ulf Bergman, Charles L. Rich Journal of Affective Disorders PsychiatryMood SymptomSuicideDepressionSocial Sciences	1996	140
Mirtazapine versus amitriptyline in the long-term treatment of depression Stuart Montgomery, Paul‐Egbert Reimitz, M. Zivkov International Clinical Psychopharmacology Psychotropic MedicationPsychopharmacologyPharmacotherapyRelapse PreventionSocial Sciences	1998	121

Page 1